{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:06:20Z","timestamp":1780614380974,"version":"3.54.1"},"reference-count":34,"publisher":"PAGEPress Publications","issue":"1","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>Cutaneous leishmaniasis (CL) is caused by Leishmania parasites. Ethiopia is one of the top ten countries with a high CL load, and Amhara National Regional State (ANRS) is one of the CL hotspot areas in the country. This study examined cutaneous leishmaniasis\u2019s epidemiology and clinical profiles in the ANRS region. It was conducted from April to October 2023 across eight Leishmaniasis Treatment Centres (LTCs). A data review was done from patients presenting to these centers between June 2018 and July 2023. Chi-square test and logistic regression were performed using SPSS-23. A total of 1729 patients with CL were recorded, resulting in an overall burden of 8.6 cases per 10,000 outpatients. Patients were from 112 districts, and most of them (71.1%) presented with localized cutaneous leishmaniasis (LCL). Approximately 12% of patients lived with the disease for over a year without treatment, while 13.2% of patients were multiple-time comers. Cutaneous leishmaniasis continues to be a significant public health issue in the ANRS region. Approximately onethird of CL patients exhibit the mucocutaneous leishmaniasis (MCL) clinical form. There has been a notable delay among CL patients in seeking diagnosis and treatment. It is essential to conduct large-scale community-based studies and studies focused on both traditional and modern treatment centers to accurately estimate the prevalence of CL in the region. Follow-up and molecular studies are crucial for enhancing our understanding of the clinical features of the disease. Furthermore, raising community awareness about CL prevention and control can help patients obtain early diagnosis and treatment.<\/jats:p>","DOI":"10.4081\/dr.2024.10089","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T06:23:45Z","timestamp":1730701425000},"source":"Crossref","is-referenced-by-count":2,"title":["Epidemiological and clinical profiles of cutaneous leishmaniasis cases in Amhara National Regional State, Northwest Ethiopia: a multicenter retrospective study"],"prefix":"10.4081","volume":"17","author":[{"given":"Bizuayehu","family":"Gashaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-2277","authenticated-orcid":false,"given":"Endalew","family":"Yizengaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-2877","authenticated-orcid":false,"given":"Endalkachew","family":"Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-7950","authenticated-orcid":false,"given":"Addisu","family":"Workineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7112-1909","authenticated-orcid":false,"given":"Adisu","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2549","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"20453","unstructured":"Ruiz-Postigo JA, Grout L, Jain S. Global leishmaniasis surveillance, 2017\u20132018, and first report on 5 additional indicators Weekly epidemiological record 2020;25:165-280."},{"key":"20454","doi-asserted-by":"crossref","unstructured":"Singh OP, Sundar S. Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol. 2014;5:296.","DOI":"10.3389\/fimmu.2014.00296"},{"key":"20455","doi-asserted-by":"crossref","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392:951-70.","DOI":"10.1016\/S0140-6736(18)31204-2"},{"key":"20456","unstructured":"World Health Organization (WHO). Leishmaniasis, 2022."},{"key":"20457","doi-asserted-by":"crossref","unstructured":"den Boer M, Argaw D, Jannin J, et al. Leishmaniasis impact and treatment access. Clin Microbiol Infect. 2011;17:1471-7.","DOI":"10.1111\/j.1469-0691.2011.03635.x"},{"key":"20458","doi-asserted-by":"crossref","unstructured":"Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581-96.","DOI":"10.1016\/S1473-3099(07)70209-8"},{"key":"20459","doi-asserted-by":"crossref","unstructured":"Neitzke-Abreu HC, Venazzi MS, de Lima Scodro RB, et al. Cutaneous leishmaniasis with atypical clinical manifestations: Case report. IDCases. 2014;1:60-2.","DOI":"10.1016\/j.idcr.2014.07.003"},{"key":"20460","unstructured":"Libardo J. G\u00f3mez RvW, Lena van Selm, Alberto Rivera, et al. Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019:1-7."},{"key":"20461","doi-asserted-by":"crossref","unstructured":"Bennis I, Thys S, Filali H, et al. Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia province, Morocco. Infect Dis Poverty. 2017;6:46.","DOI":"10.1186\/s40249-017-0267-5"},{"key":"20462","doi-asserted-by":"crossref","unstructured":"Mengistu G, Laskay T, Gemetchu T, et al. Cutaneous leishmaniasis in south-western Ethiopia: Ocholo revisited. Trans R Soc Trop Med Hyg. 1992;86:149-53.","DOI":"10.1016\/0035-9203(92)90546-O"},{"key":"20463","doi-asserted-by":"crossref","unstructured":"Yizengaw E, Nibret E, Yismaw G, et al. Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia. Skin health and Disease. 2023:1-8.","DOI":"10.1002\/ski2.229"},{"key":"20464","doi-asserted-by":"crossref","unstructured":"Shita EY, Nibret E, Munshea A, et al. Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis. Int J Dermatol. 2022;61:1336-45.","DOI":"10.1111\/ijd.16265"},{"key":"20465","doi-asserted-by":"crossref","unstructured":"Alvar J, Canavate C, Gutierrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997;10:298-319.","DOI":"10.1128\/CMR.10.2.298"},{"key":"20466","doi-asserted-by":"crossref","unstructured":"Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.","DOI":"10.1371\/journal.pone.0035671"},{"key":"20467","unstructured":"Guideline for Diagnosis, Treatment and Prevention of Leishmaniasis in Ethiopia 2013."},{"key":"20468","unstructured":"Gashaw G. Yizengaw E, Sebsibe B, et al. Clinical Manifestations of Cutaneous Leishmaniasis (CL): Does Elevated Blood Sugar Level have Implications for Clinical Management of CL? Ethiopian Journal of Health Development. 2023;37."},{"key":"20469","doi-asserted-by":"crossref","unstructured":"Eshetu B, Mamo H. Cutaneous leishmaniasis in north-central Ethiopia: trend, clinical forms, geographic distribution, and determinants. Trop Med Health. 2020;48:39.","DOI":"10.1186\/s41182-020-00231-w"},{"key":"20470","doi-asserted-by":"crossref","unstructured":"van Henten S, Bialfew F, Hassen S, et al.Treatment of cutaneous leishmaniasis with sodium stibogluconate and allopurinol in a routine setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges. Trop Med Infect Dis. 2023;8.","DOI":"10.1101\/2023.07.05.23292210"},{"key":"20471","doi-asserted-by":"crossref","unstructured":"Neway B.Y.S, Mebrat B, Ayalew G. Prevalence of cutaneous leishmaniasis in alert center, retrospective analysis, Addis Ababa. Journal of Health Systems and Policies. 2021;3:110-21.","DOI":"10.52675\/jhesp.949565"},{"key":"20472","doi-asserted-by":"crossref","unstructured":"van Henten S, Adriaensen W, Fikre H, et al. Cutaneous Leishmaniasis Due to Leishmania aethiopica. EClinicalMedicine. 2018;6:69-81.","DOI":"10.1016\/j.eclinm.2018.12.009"},{"key":"20473","doi-asserted-by":"crossref","unstructured":"Fikre H, Mohammed R, Atinafu S, et al. Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia. Trop Med Int Health. 2017;22:1293-301.","DOI":"10.1111\/tmi.12928"},{"key":"20474","doi-asserted-by":"crossref","unstructured":"Yohannes M, Abebe Z, Boelee E. Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia. PLoS Negl Trop Dis. 2019;13:e0007722.","DOI":"10.1371\/journal.pntd.0007722"},{"key":"20475","doi-asserted-by":"crossref","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282:20143085.","DOI":"10.1098\/rspb.2014.3085"},{"key":"20476","doi-asserted-by":"crossref","unstructured":"Davies CR, Gavgani ASM. Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitology. 1999;119:247-57.","DOI":"10.1017\/S0031182099004680"},{"key":"20477","doi-asserted-by":"crossref","unstructured":"Okwor I, Mou Z, Liu D, et al. Protective immunity and vaccination against cutaneous leishmaniasis. Front Immunol. 2012;3:128.","DOI":"10.3389\/fimmu.2012.00128"},{"key":"20478","doi-asserted-by":"crossref","unstructured":"Seife AKBT, Zewdu TF, Ayal A, et al. Treatment Patterns and Effectivness of Anti-Leishmaniasis Agents for Patients with Cutaneous Leishmaniasis at Boru Meda Hospital, South Wollo, North East Ethiopia, 2017\/18. Journal of Clinical & Experimental Dermatology Research. 2018;9.","DOI":"10.4172\/2155-9554.1000450"},{"key":"20479","doi-asserted-by":"crossref","unstructured":"Negera E, Gadisa E, Yamuah L, et al. Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification. Trans R Soc Trop Med Hyg. 2008;102:883-90.","DOI":"10.1016\/j.trstmh.2008.03.021"},{"key":"20480","doi-asserted-by":"crossref","unstructured":"Tilahun WAT, Mulatu G. Magnitude and associated factors of cutaneous leishmaniasis; in Mekelle city, Ayder referral hospital, Tigray, Northern Ethiopia, 2014 Clinical Medicine Research. 2014;3:.","DOI":"10.11648\/j.cmr.20140306.16"},{"key":"20481","doi-asserted-by":"crossref","unstructured":"Bisetegn H, Zeleke AJ, Gadisa E, et al. Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia. PLoS Negl Trop Dis. 2020;14:e0008507.","DOI":"10.1371\/journal.pntd.0008507"},{"key":"20482","doi-asserted-by":"crossref","unstructured":"van Henten S, Tesfaye AB, Abdela SG, et al. Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia. PLoS Negl Trop Dis. 2021;15:e0009460.","DOI":"10.1371\/journal.pntd.0009460"},{"key":"20483","doi-asserted-by":"crossref","unstructured":"Cantanhede LM, da Silva Junior CF, Ito MM, et al. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. PLoS Negl Trop Dis. 2015;9:e0004079.","DOI":"10.1371\/journal.pntd.0004079"},{"key":"20484","doi-asserted-by":"crossref","unstructured":"Aberra L, Abera A, Belay T, et al. Evaluation of microcapillary culture method for the isolation of Leishmania aethiopica parasites from patients with cutaneous lesions in Ethiopia. Diagn Progn Res. 2019;3:4.","DOI":"10.1186\/s41512-019-0051-z"},{"key":"20485","doi-asserted-by":"crossref","unstructured":"A Lemma WAF, T Gemetchu, P M Preston, et al. A Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands. Ann Trop Med Parasitol. 1969;63:455-72.","DOI":"10.1080\/00034983.1969.11686649"},{"key":"20486","doi-asserted-by":"crossref","unstructured":"Padovese V, Terranova M, Toma L, et al. Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Trans R Soc Trop Med Hyg. 2009;103:707-11.","DOI":"10.1016\/j.trstmh.2009.02.023"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/journals.pagepress.net\/dr\/article\/download\/10089\/9476","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.pagepress.net\/dr\/article\/download\/10089\/9583","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.pagepress.net\/dr\/article\/download\/10089\/9476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:57:53Z","timestamp":1774004273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.pagepress.net\/dr\/article\/view\/10089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,6]]}},"URL":"https:\/\/doi.org\/10.4081\/dr.2024.10089","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"value":"2036-7406","type":"electronic"},{"value":"2036-7392","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}